XTANDI is a prescription medicine used to treat men with prostate cancer that:
- no longer responds to a hormone therapy or surgical treatment to lower testosterone
- has spread to other parts of the body and responds to a hormone therapy or surgical treatment to lower testosterone
OR
It is not known if XTANDI is safe and effective in females or children.
XTANDI can slow advanced prostate cancer progression while you focus more on what you love
XTANDI has been studied in men with advanced prostate cancer. Men in each study either had surgery to lower testosterone or were taking hormone therapy. In our studies, progression was defined as the cancer getting worse, as measured by scans, or if the patient died for any reason.
XTANDI is FDA approved to treat 3 forms of advanced prostate cancer.
Non-metastatic castration-resistant prostate cancer (nmCRPC)
In a study where the cancer had not spread to other parts of the body and no longer responded to treatment to lower testosterone, XTANDI lowered the chance of progression by 71%.
Metastatic castration-sensitive prostate cancer (mCSPC)
In a study where the cancer had spread to other parts of the body and still responded to treatment to lower testosterone, XTANDI lowered the chance of progression by 61%.
Metastatic castration-resistant prostate cancer (mCRPC)
In a study where the cancer had spread to other parts of the body and no longer responded to treatment to lower testosterone, XTANDI lowered the chance of progression by 83%.
Select Safety Information
XTANDI may cause serious side effects including seizure. If you take XTANDI, you may be at risk of having a seizure. Avoid activities where a sudden loss of consciousness could seriously harm you or someone else. Tell your doctor right away if you lose consciousness or have a seizure.
Stay informed
Whether you’re a patient or caregiver, you’re not fighting alone. We’re here for you with
tools, tips, information, and support.
with Pat, his wife and caregiver.
Resources that can help you get and pay for XTANDI
The XTANDI Patient Savings ProgramSM allows eligible patients with commercial insurance* to pay as little as $0 per prescription. Save up to a maximum of $25,000 per calendar year.
